ArticleIndian journal of dermatology
Efficacy of Heartfulness Meditation as Adjunctive Therapy for Moderate to Severe Psoriasis: A Randomised Controlled Trial.
Article in Indian journal of dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Psoriasis is a chronic inflammatory skin condition significantly impacting quality of life. Traditional treatments, such as methotrexate, are effective but often have side effects and do not address psychosocial stressors. Heartfulness meditation, which emphasises relaxation and self-awareness, may complement standard treatments by reducing stress. Objective: The primary objective was to evaluate the effectiveness of heartfulness meditation as an adjunct to methotrexate in achieving a 75% reduction in Psoriasis Area and Severity Index (PASI 75) at 4 months. Secondary objectives included changes in body surface area (BSA), Dermatology Life Quality Index (DLQI), Perceived Stress Scale (PSS), Pittsburgh Sleep Quality Index (PSQI), and biomarkers (serum cortisol and IL-6 levels). Methods: This randomised controlled trial was conducted at the dermatology outpatient department of the institute, India, involving 50 adults (18-60 years) with moderate to severe psoriasis (PASI ≥10 or BSA involvement ≥10%). Participants were randomised into two groups: the intervention group (n = 25) received heartfulness meditation alongside methotrexate (7.5 mg to 25 mg weekly), while the control group (n = 25) received methotrexate alone. Randomisation used a computer-generated sequence, with blinding applied to outcome assessors and data analysts. Results: Of the 50 participants randomised, 44 were included in the final analysis. PASI 75 was achieved in 61.1% of the intervention group compared to 52.38% in the control group ( Conclusion: Heartfulness meditation may offer additional benefits when combined with methotrexate for treating moderate to severe psoriasis, though findings were not statistically significant. Larger studies are needed to confirm these results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.